Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole

AIDS Patient Care and STDs

Volumn 15, Issue 5, 2001, Pages 263-269

  Fisher, R G ^a   Nageswaran, S ^b   Valentine, M E ^c   McKinney, R E ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BODY SURFACE; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG TOLERABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PROPHYLAXIS; RASH; SEPSIS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0035021180     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910152050784     Document Type: Article

References (23)

1. Efficacy of trimethoprim and sulfamethoxazole in the prevention of Pneumocystis carinii pneumonitis
2. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis
3. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia
4. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis
5. Chemoprophylaxis for Pneumocystis carinii pneumonitis: Outcome of unstructured delivery
6. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency disease
7. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients
8. Safety and efficacy of sulfamethoxazole and trimethophrim prophylaxis for Pneumocystis carinii pneumonia in AIDS
9. Low-dose trimethoprim-sulfamethoxazole alone and in association with zidovudine for prevention and treatment of murine Pneumocystis carinii pneumonia
10. Predictors of failure of Pneumocystis carinii pneumonia prophylaxis
11. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function
12. Pediatric HIV classification for children less than 13 years of age
13. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.2 × 10(9)/L of more. Effect on viral, opportunistic, and bacterial infections
14. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection
15. If nothing goes wrong, is everything all right? Interpreting zero numerators
16. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
17. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
18. Perturbation of CD4 and CD8 T-cell repertoires during progression to AIDS and regulation of the CD4 repertoire during antiretroviral therapy
19. Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease
20. Community-acquired bacteremia in HIV-positive patients: Protective benefit of co-trimoxazole
21. Effect of trimethoprim-sulfamethoxazole as pneumocystis carinii pneumonia prophylaxis on bacterial illness, pneumocystis carinii pneumonia, and death in persons with AIDS
22. Survival in children with perinatally acquired HIV infection
23. Pneumococcal bacteremia in children with HIV infection